4//SEC Filing
Lehr Martin A. 4
Accession 0001842952-23-000008
CIK 0001842952other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:03 PM ET
Size
6.0 KB
Accession
0001842952-23-000008
Insider Transaction Report
Form 4
Lehr Martin A.
DirectorChief Executive Officer
Transactions
- Purchase
Common Stock
2023-01-23$0.72/sh+6,839$4,901→ 136,205 total
Holdings
- 820,190(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 15, 2022.
- [F2]The price reported above is a weighted average price. These shares were acquired in several transactions at prices ranging from $0.7052 - $0.7251. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Context Therapeutics Inc.
CIK 0001842952
Entity typeother
Related Parties
1- filerCIK 0001861989
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:03 PM ET
- Size
- 6.0 KB